Next |
home / stock / bgne / bgne message board
Subject | By | Source | When |
---|---|---|---|
BGNE having a nice bounce and a good, | MiamiGent | investorshub | 07/05/2023 7:28:03 PM |
Thoughts on where this is headed? | StockLearner2011 | investorshub | 07/03/2023 9:49:33 PM |
Found an interesting article | luke424 | investorshub | 06/30/2023 1:45:08 AM |
$BGNE must see | StockLearner2011 | investorshub | 06/28/2023 1:49:55 AM |
here we go bulls news is here | StockLearner2011 | investorshub | 06/22/2023 3:12:55 PM |
Have a look at this | StockLearner2011 | investorshub | 06/22/2023 12:11:10 PM |
$BGNE MomentumIts trading | north40000 | investorshub | 06/21/2023 3:35:51 AM |
The trading last up | StockLearner2011 | investorshub | 06/20/2023 3:13:09 PM |
$BGNE short squeeze | luke424 | investorshub | 06/18/2023 5:16:26 AM |
MomentumIts now up | SweepsMcGee | investorshub | 06/14/2023 10:32:03 AM |
$BGNE where is the squeeze? | StockLearner2011 | investorshub | 06/12/2023 12:02:18 AM |
$BGNE should we be shorting? | StockLearner2011 | investorshub | 04/30/2023 7:59:54 PM |
$BGNE The trading | north40000 | investorshub | 04/29/2023 7:28:01 PM |
Long and strong lets hope im right | luke424 | investorshub | 04/27/2023 12:28:02 AM |
$BGNE short squeeze | MiamiGent | investorshub | 04/24/2023 3:35:51 PM |
Price gaining | StockLearner2011 | investorshub | 04/23/2023 2:43:18 PM |
Looks pretty positive | StockLearner2011 | investorshub | 04/17/2023 6:19:38 AM |
$BGNE MomentumIts now | StockLearner2011 | investorshub | 04/05/2023 2:19:08 AM |
$BGNE $271.915 +$6.91 (+2.609%) | MiamiGent | investorshub | 01/19/2023 2:49:53 PM |
BGNE presently $269.42 +$6.19 (+2.35%) | MiamiGent | investorshub | 01/13/2023 7:42:57 PM |
News, Short Squeeze, Breakout and More Instantly...
Arm D of SEQUOIA study evaluated treatment-naïve patients with high-risk chronic lymphocytic leukemia or small lymphocytic lymphoma with del(17p) and/or TP53 mutation Preliminary data suggest promising efficacy and tolerability Safety profile was consistent with results o...
BeiGene (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company, and NewBridge Pharmaceuticals have jointly decided to conclude their partnership. This strategic decision aligns with BeiGene’s goals to expand its presence and directly manage operations in the MENA region. T...
BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company, today announced the Company will participate in the Goldman Sachs 45th Annual Global Healthcare Conference on Tuesday, June 11, 2024 with a fireside chat at 1:20 pm EDT. Live webcast of this event can be acce...